Alexander A Brescia1, Jennifer F Waljee2, Hsou Mei Hu3, Michael J Englesbe3, Chad M Brummett4, Pooja A Lagisetty5, Kiran H Lagisetty3. 1. Department of Cardiac Surgery, University of Michigan, Ann Arbor, Michigan; Center for Healthcare Outcomes and Policy, University of Michigan, Ann Arbor, Michigan. Electronic address: abrescia@med.umich.edu. 2. Center for Healthcare Outcomes and Policy, University of Michigan, Ann Arbor, Michigan; Department of Surgery, University of Michigan, Ann Arbor, Michigan. 3. Department of Surgery, University of Michigan, Ann Arbor, Michigan. 4. Department of Anesthesiology, University of Michigan, Ann Arbor, Michigan. 5. Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan.
Abstract
BACKGROUND: New persistent opioid use occurs in 3% to 14% of patients after elective surgery, but is poorly described after cardiothoracic surgery. We examined the association of prescription size with new persistent opioid use after cardiothoracic surgery. METHODS: Opioid-naive Medicare patients undergoing cardiothoracic surgery between 2009 and 2015 were identified. Patients who filled an opioid prescription between 30 days before surgery and 14 days after discharge and with continuous Medicare enrollment 12 months before and 6 months after surgery were selected (n = 24,549). New persistent use was defined as continued prescription fills 91 to 180 days after surgery. Prescription size was reported in oral morphine equivalents. Multivariable regression was performed for risk adjustment, and new persistent use rate was estimated. RESULTS: Patient age was 71 ± 8 years, 9222 (38%) were female, and 20,898 (85%) were white. Overall new persistent use was 12.8% (3153 of 24,549), and declined yearly from 17% in 2009 to 7.1% in 2015 (P < .001). Prescription size, preoperative prescription fills, black race, gastrointestinal complications, disability status, open lung resection, dual eligibility (Medicare and Medicaid), drug and substance abuse, female sex, tobacco use, high comorbidity, pain disorders, longer hospital stay, and younger age were associated with new persistent use. Adjusted new persistent use was 19.6% (95% confidence interval, 18.7% to 20.4%) among patients prescribed more than 450 oral morphine equivalents, compared with 10.4% (95% confidence interval, 9.9% to 10.8%) among those prescribed 200 oral morphine equivalents or less (P < .001). CONCLUSIONS: Size and timing of perioperative opioid prescriptions were the strongest predictors of new persistent opioid use after cardiothoracic surgery. Modifiable risk factors such as prescription size should be targeted to reduce new persistent use.
BACKGROUND: New persistent opioid use occurs in 3% to 14% of patients after elective surgery, but is poorly described after cardiothoracic surgery. We examined the association of prescription size with new persistent opioid use after cardiothoracic surgery. METHODS: Opioid-naive Medicare patients undergoing cardiothoracic surgery between 2009 and 2015 were identified. Patients who filled an opioid prescription between 30 days before surgery and 14 days after discharge and with continuous Medicare enrollment 12 months before and 6 months after surgery were selected (n = 24,549). New persistent use was defined as continued prescription fills 91 to 180 days after surgery. Prescription size was reported in oral morphine equivalents. Multivariable regression was performed for risk adjustment, and new persistent use rate was estimated. RESULTS:Patientage was 71 ± 8 years, 9222 (38%) were female, and 20,898 (85%) were white. Overall new persistent use was 12.8% (3153 of 24,549), and declined yearly from 17% in 2009 to 7.1% in 2015 (P < .001). Prescription size, preoperative prescription fills, black race, gastrointestinal complications, disability status, open lung resection, dual eligibility (Medicare and Medicaid), drug and substance abuse, female sex, tobacco use, high comorbidity, pain disorders, longer hospital stay, and younger age were associated with new persistent use. Adjusted new persistent use was 19.6% (95% confidence interval, 18.7% to 20.4%) among patients prescribed more than 450 oral morphine equivalents, compared with 10.4% (95% confidence interval, 9.9% to 10.8%) among those prescribed 200 oral morphine equivalents or less (P < .001). CONCLUSIONS: Size and timing of perioperative opioid prescriptions were the strongest predictors of new persistent opioid use after cardiothoracic surgery. Modifiable risk factors such as prescription size should be targeted to reduce new persistent use.
Authors: Yih-Ing Hser; Larissa J Mooney; Andrew J Saxon; Karen Miotto; Douglas S Bell; Yuhui Zhu; Di Liang; David Huang Journal: J Addict Med Date: 2017 Jul/Aug Impact factor: 3.702
Authors: Katelyn G Bennett; Brian P Kelley; Alexis D Vick; Jay S Lee; Vidhya Gunaseelan; Chad M Brummett; Jennifer F Waljee Journal: Plast Reconstr Surg Date: 2019-01 Impact factor: 4.730
Authors: Ryan Howard; Brian Fry; Vidhya Gunaseelan; Jay Lee; Jennifer Waljee; Chad Brummett; Darrell Campbell; Elizabeth Seese; Michael Englesbe; Joceline Vu Journal: JAMA Surg Date: 2019-01-16 Impact factor: 14.766
Authors: Brian T Bateman; Naida M Cole; Ayumi Maeda; Sara M Burns; Timothy T Houle; Krista F Huybrechts; Caitlin R Clancy; Stephanie B Hopp; Jeffrey L Ecker; Holly Ende; Kasey Grewe; Beatriz Raposo Corradini; Robert E Schoenfeld; Keerthana Sankar; Lori J Day; Lynnette Harris; Jessica L Booth; Pamela Flood; Melissa E Bauer; Lawrence C Tsen; Ruth Landau; Lisa R Leffert Journal: Obstet Gynecol Date: 2017-07 Impact factor: 7.661
Authors: Jay Soong-Jin Lee; Hsou Mei Hu; Anthony L Edelman; Chad M Brummett; Michael J Englesbe; Jennifer F Waljee; Jeffrey B Smerage; Jennifer J Griggs; Hari Nathan; Jacqueline S Jeruss; Lesly A Dossett Journal: J Clin Oncol Date: 2017-10-19 Impact factor: 44.544
Authors: Brandon C Maughan; Elliot V Hersh; Frances S Shofer; Kathryn J Wanner; Elizabeth Archer; Lee R Carrasco; Karin V Rhodes Journal: Drug Alcohol Depend Date: 2016-09-20 Impact factor: 4.492
Authors: Karsten Bartels; Lena M Mayes; Colleen Dingmann; Kenneth J Bullard; Christian J Hopfer; Ingrid A Binswanger Journal: PLoS One Date: 2016-01-29 Impact factor: 3.240
Authors: Benjamin A Abrams; Kimberly A Murray; Katharine Mahoney; Kristen M Raymond; Shannon K McWilliams; Stephanie Nichols; Elham Mahmoudi; Lena M Mayes; Ana Fernandez-Bustamante; John D Mitchell; Robert A Meguid; Giorgio Zanotti; Karsten Bartels Journal: Ann Thorac Surg Date: 2020-06-01 Impact factor: 4.330
Authors: Mark A Lockett; Ralph C Ward; Jenna L McCauley; David J Taber; Mulugeta Gebregziabher; Robert A Cina; William T Basco; Patrick D Mauldin; Sarah J Ball Journal: Surg Open Sci Date: 2022-05-20
Authors: Ryan Howard; Vidhya Gunaseelan; Chad Brummett; Jennifer Waljee; Michael Englesbe; Dana Telem Journal: Ann Surg Date: 2020-10-15 Impact factor: 13.787
Authors: Alexander A Brescia; Melissa J Clark; Patricia F Theurer; Shelly C Lall; Hassan W Nemeh; Richard S Downey; David E Martin; Reza R Dabir; Zewditu E Asfaw; Phillip L Robinson; Steven D Harrington; Divyakant B Gandhi; Jennifer F Waljee; Michael J Englesbe; Chad M Brummett; Richard L Prager; Donald S Likosky; Karen M Kim; Kiran H Lagisetty Journal: Ann Thorac Surg Date: 2020-12-04 Impact factor: 5.102
Authors: Ryan Howard; Craig S Brown; Yen-Ling Lai; Vidhya Gunaseelan; Kao-Ping Chua; Chad Brummett; Michael Englesbe; Jennifer Waljee; Mark C Bicket Journal: Ann Surg Date: 2021-06-04 Impact factor: 12.969